Intramuscular versus subcutaneous injection of soluble and lispro insulin: Comparison of metabolic effects in healthy subjects

Diabetic Medicine

Volumn 15, Issue 9, 1998, Pages 747-751

  Rave, K ^a   Heise, T ^a   Weyer, C ^a   Herrnberger, J ^a   Bender, R ^a   Hirschberger, S ^b   Heinemann, L ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Novo Nordisk Pharma GmbH   (Germany)

Author keywords

Glucose clamp; Injection technique; Metabolic control; Rapid acting insulin analogues; Soluble insulin

Indexed keywords

INSULIN LISPRO; NEUTRAL INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; DIABETES MELLITUS; DRUG METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLIC REGULATION; MUSCLE BLOOD FLOW; NORMAL HUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; TIME FACTORS;

EID: 0031877722     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199809)15:9<747::AID-DIA664>3.0.CO;2-V     Document Type: Article

References (20)

1. Thow JC, Coulthard A, Home PD. Insulin injection site tissue depths and localization of a simulated insulin bolus using a novel air contrast ultrasonographic technique in insulin treated diabetic subjects. Diabetic Med 1992; 9: 915-920.
2. Frid A, Cunnarsson R, Güntner P, Linde B. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988; 11: 41-45.
3. Vaag A, Handberg A, Lauritzen M, Henriksen JE, Pedersen KD, Beck-Nielsen H. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 1990; 13: 74-76.
4. Vaag A, Pedersen KD, Lauritzen M, Hildebrandt P, Beck Nielsen H. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabetic Med 1990; 7: 335-342.
5. Henriksen JE, Vaag A, Hansen IR, Lauritzen M, Djurhuus MS, Beck Nielsen H. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site. Diabetic Med 1991; 8: 453-457.
6. Thow JC, Johnson AB, Fulcher G, Home PD. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabetic Med 1990; 7: 600-602.
7. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro (B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402.
8. Heinemann L, Kapitza C, Starke AAR, Heise T. Time action profile of the insulin analogue B28Asp. Diabetic Med 1997; 13: 683-684.
9. Frid A, Ostman J, Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care 1990; 13: 473-477.
10. Heinemann L, Heise T, Kamper K. Biotrans: description of a data transfer program for the Biostator. Int J Artif Organs 1993; 16: 213-217.
11. Bender R, Heinemann L. Fitting nonlinear regression models with correlated errors to individual pharmakodynamic data using SAS software. J Pharma Biophar 1995; 23: 87-100.
12. Spraul M, Chantelau E, Koumoulidou J, Berger M. Subcutaneous or nonsubcutaneous injection of insulin. Diabetes Care 1988; 11: 733-736.
13. Kang S, Owens DR, Vora JP, Brange J. Comparison of insulin analogue B9AspB27Glu and soluble human insulin-treated diabetes. Lancet 1990; 335: 303-306.
14. Kang S, Creagh FM, Peters JR, Brange J, Volund A, Owens DR. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type 1 diabetic subjects. Diabetes Care 1991; 14: 571-577.
15. Heinemann L, Heise T, Trautmann ME, Ampudia J, Starke AAR, Berger M. Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: using the rapid acting insuln analogue [Lys(B28),Pro(B29] human insulin. Diabetic Med 1996; 13: 625-629.
16. ter Braak E, Woodworth JR, Bianchi R, Cetimelle B, Ethelens DW, Thijssen JH. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 1996; 19: 1437-1440.
17. Vora JP, Burch A, Peters JR, Owens DR. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 1992; 15: 1484-1493.
18. Frid A, Linde B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabetic Med 1992; 9: 236-239.
19. Polak M, Beregszaszi M, Belarbi N, Benali K, Hassau M, Czetnichow P. Subcutaneous or intramuscular injections of insulin in children. Diabetes Care 1996; 19: 1434-1436.
20. Heise T, Weyer C, Rauhaus M, Stiefelhagen O, Heinemann L. Variability of the metabolic effect of s.c. injected regular insulin and the rapid acting insulin-analogue B28Asp. Diabetes 1997; 46 (suppl 1): 330A.